Seek Returns

ABBV vs. XOM: AbbVie vs. ExxonMobil Stock Comparison

How do AbbVie (ABBV) and ExxonMobil (XOM) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

AbbVie (ABBV) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas ExxonMobil (XOM) belongs to Energy (Energy) — their GICS classifications point to very different parts of the market.

Company profile comparison for AbbVie (ABBV) and ExxonMobil (XOM)
Profile ItemABBVXOM
NameAbbVie Inc.ExxonMobil Holdings Corporation
Country/RegionUnited StatesUnited States
GICS SectorHealth CareEnergy
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesEnergy
GICS IndustryBiotechnologyOil, Gas & Consumable Fuels
GICS Sub-IndustryBiotechnologyIntegrated Oil & Gas
Market Capitalization514.92 billion USD676.62 billion USD
CurrencyUSDUSD
ExchangeNYSENYSE
Listing DateJanuary 2, 2013January 2, 1962
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

ABBV
XOM
GSPC
Loading price history…
AbbVie (ABBV) vs. ExxonMobil (XOM), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for AbbVie (ABBV) and ExxonMobil (XOM). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for AbbVie (ABBV) and ExxonMobil (XOM). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for AbbVie (ABBV) and ExxonMobil (XOM)
MetricABBVXOM
Total Return (1Y)37.33%44.48%
Total Return (3Y, Annualized)32.74%20.83%
Total Return (5Y, Annualized)24.73%24.20%

Risk Profile

Drawdown History

ABBV
XOM
GSPC
Loading price history…
AbbVie (ABBV) vs. ExxonMobil (XOM), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for AbbVie (ABBV) and ExxonMobil (XOM). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for AbbVie (ABBV) and ExxonMobil (XOM)
MetricABBVXOM
Volatility (1Y, Annualized)25.65%27.17%
Beta (5Y)0.210.19
Max Drawdown (5Y)-21.92%-20.51%
Avg. Volume (3M)4.76M13.57M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
ABBV and XOM are plotted by 1-year volatility (risk) and 1-year return. Each dashed Capital Allocation Line uses that stock's own industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for AbbVie (ABBV) and ExxonMobil (XOM)
MetricABBVXOM
Sharpe Ratio (1Y)1.291.48
Sortino Ratio (1Y)2.022.17

Profitability

ROE (TTM)

Capital efficiency shows on one side only: ExxonMobil (XOM) earns 15.53% on shareholders’ equity, ranked against its industry; AbbVie (ABBV) has no ROE this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
ABBV
--

XOM

Energy industry group

15.53%

Max
53.85%
Q3
24.79%
XOM
15.53%
Median
12.85%
Q1
2.03%
Min
-29.09%
Loading chart…
AbbVie (ABBV) vs. ExxonMobil (XOM): ABBV does not report ROE, so it has no value marker; XOM is benchmarked against the Energy industry group.

Net Margin (TTM)

AbbVie (ABBV) at 15.67% retains a top-quartile share of revenue as profit, ahead of ExxonMobil (XOM) at 10.46%, which keeps about the industry-typical share.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

15.67%

Max
18.05%
ABBV
15.67%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

XOM

Energy industry group

10.46%

Max
56.92%
Q3
22.92%
XOM
10.46%
Median
10.10%
Q1
0.07%
Min
-27.38%
Loading chart…
AbbVie (ABBV) vs. ExxonMobil (XOM): A comparison of their net margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Energy industry group benchmarks.

Operating Margin (TTM)

AbbVie (ABBV) at 39.59% operates in the top operating margin quartile, ahead of ExxonMobil (XOM) at 16.98%, which runs around its industry’s norm.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

39.59%

Max
83.12%
ABBV
39.59%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%

XOM

Energy industry group

16.98%

Max
71.31%
Q3
33.75%
Median
18.73%
XOM
16.98%
Q1
6.94%
Min
-24.52%
Loading chart…
AbbVie (ABBV) vs. ExxonMobil (XOM): A comparison of their operating margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Energy industry group benchmarks.

Profitability Metrics

Profitability metrics for AbbVie (ABBV) and ExxonMobil (XOM)
MetricABBVXOM
ROE (TTM)--15.53%
ROA (TTM)10.74%6.75%
Net Margin (TTM)15.67%10.46%
Operating Margin (TTM)39.59%16.98%
Gross Margin (TTM)73.72%29.81%

Growth

Revenue Growth

Both AbbVie (ABBV) at 8.57% and ExxonMobil (XOM) at -4.52% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
AbbVie (ABBV) vs. ExxonMobil (XOM): A comparison of their Revenue Growth across different time periods.

EPS Growth

Both AbbVie (ABBV) at -0.84% and ExxonMobil (XOM) at -14.54% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

Loading chart…
AbbVie (ABBV) vs. ExxonMobil (XOM): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for AbbVie (ABBV) and ExxonMobil (XOM)
MetricABBVXOM
Revenue Growth (YoY)8.57%-4.52%
Revenue Growth (3Y CAGR)1.75%-6.69%
EPS Growth (YoY)-0.84%-14.54%
EPS Growth (3Y CAGR)-29.03%-20.35%

Financial Strength

Current Ratio (MRQ)

ExxonMobil (XOM) at 1.19 keeps current ratio within its industry’s typical mid-range, while AbbVie (ABBV) at 0.87 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for ABBV.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.87

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
ABBV
0.87
Min
0.10

XOM

Energy industry group

1.19

Max
3.64
Q3
2.21
Median
1.41
XOM
1.19
Q1
0.88
Min
0.24
Loading chart…
AbbVie (ABBV) vs. ExxonMobil (XOM): A comparison of their current ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Energy industry group benchmarks.

Debt / Equity (MRQ)

Only one side’s leverage can be read here: ExxonMobil (XOM) carries debt-to-equity ratio of 0.13 against its industry range, while AbbVie (ABBV) reports no figure this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00
ABBV
--

XOM

Energy industry group

0.13

Max
1.75
Q3
0.93
Median
0.54
Q1
0.30
XOM
0.13
Min
0.00
Loading chart…
AbbVie (ABBV) vs. ExxonMobil (XOM): ABBV does not report debt-to-equity ratio, so it has no value marker; XOM is benchmarked against the Energy industry group.

Financial Strength Metrics

Financial strength metrics for AbbVie (ABBV) and ExxonMobil (XOM)
MetricABBVXOM
Current Ratio (MRQ)0.871.19
Debt / Equity (MRQ)--0.13
Net Debt / EBITDA2.210.28

Dividends

Dividend Yield (TTM)

ExxonMobil (XOM) at 2.49% pays an industry-typical yield; AbbVie (ABBV) at 2.40% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.40%

ABBV
2.40%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

XOM

Energy industry group

2.49%

Max
8.57%
Q3
3.58%
XOM
2.49%
Median
1.71%
Q1
0.00%
Min
0.00%
Loading chart…
AbbVie (ABBV) vs. ExxonMobil (XOM): A comparison of their dividend yield against their respective Pharmaceuticals, Biotechnology & Life Sciences and Energy industry group benchmarks.

Dividend Payout Ratio (TTM)

AbbVie (ABBV) reports payout ratio above 100% at 117.35%, meaning dividends exceeded current-period earnings and sustainability needs extra context. Meanwhile ExxonMobil (XOM) reports 42.39%, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

117.35%

ABBV
117.35%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

XOM

Energy industry group

42.39%

Max
133.24%
Q3
53.31%
XOM
42.39%
Median
25.24%
Q1
0.00%
Min
0.00%
Loading chart…
AbbVie (ABBV) vs. ExxonMobil (XOM): A comparison of their payout ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Energy industry group benchmarks.

Dividend Metrics

Dividend metrics for AbbVie (ABBV) and ExxonMobil (XOM)
MetricABBVXOM
Dividend Yield (TTM)2.40%2.49%
Dividend Payout Ratio (TTM)117.35%42.39%

Valuation

P/E Ratio (TTM)

ExxonMobil (XOM) at 17.06 is near its industry’s usual P/E ratio, while AbbVie (ABBV) at 50.05 sits in the richer quartile — ABBV needs stronger growth or earnings quality to justify the premium.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

50.05

Max
85.34
ABBV
50.05
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07

XOM

Energy industry group

17.06

Max
39.54
Q3
21.72
XOM
17.06
Median
12.19
Q1
7.71
Min
2.99
Loading chart…
AbbVie (ABBV) vs. ExxonMobil (XOM): A comparison of their P/E ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Energy industry group benchmarks.

P/S Ratio (TTM)

On P/S ratio, both AbbVie (ABBV) at 7.80 and ExxonMobil (XOM) at 1.74 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

7.80

Max
58.18
Q3
25.77
ABBV
7.80
Median
7.30
Q1
3.01
Min
0.01

XOM

Energy industry group

1.74

Max
5.40
Q3
2.85
XOM
1.74
Median
1.69
Q1
0.88
Min
0.00
Loading chart…
AbbVie (ABBV) vs. ExxonMobil (XOM): A comparison of their P/S ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Energy industry group benchmarks.

P/B Ratio (MRQ)

AbbVie (ABBV) reports a negative P/B ratio of -112.34, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile ExxonMobil (XOM) reports 2.55, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

-112.34

Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59
ABBV
-112.34

XOM

Energy industry group

2.55

Max
4.21
XOM
2.55
Q3
2.38
Median
1.51
Q1
1.08
Min
0.01
Loading chart…
AbbVie (ABBV) vs. ExxonMobil (XOM): A comparison of their P/B ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Energy industry group benchmarks.

Valuation Metrics

Valuation metrics for AbbVie (ABBV) and ExxonMobil (XOM)
MetricABBVXOM
P/E Ratio (TTM)50.0517.06
P/S Ratio (TTM)7.801.74
P/B Ratio (MRQ)-112.342.55
Free Cash Flow Yield (TTM)3.44%4.19%